Sofie Peirs - Concepedia

Author

Sofie Peirs

Ghent University Hospital ORCID

Also Known As

S Peirs, S. Peirs, Sofie Peirs

Publications

Citations

H-Index

Concepts

All Affiliations

Ghent University Hospital Ghent University Cancer Research Institute Ghent VIB-UGent Center for Inflammation Research Children's Hospital of Philadelphia

About

Sofie Peirs is an author at Ghent University Hospital specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	131
2	Cell Biology	3	3	131
3	Immunology	2	2	111
4	Cell Signaling	1	1	44
5	Epigenetics	1	1	20

Sofie Peirs

Publications

823

Citations

H-Index

Page 1

	Year	Citations
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia Sofie Peirs, Filip Matthijssens, Steven Goossens, Blood	2014	270
A Novel <scp>l</scp> -Asparaginase with low <scp>l</scp> -Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias <i>In Vivo</i> Hien Anh Thi Nguyen, Ying Su, Jenny Y. Zhang, Cancer Research	2018	125
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling Steven Goossens, Enrico Radaelli, Odile Blanchet, Nature Communications	2015	87
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia Qi Jin, Carlos A. Martínez, Kelly M. Arcipowski, Clinical Cancer Research	2018	87
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia Sofie Peirs, Viktoras Frismantas, Filip Matthijssens, Leukemia Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyTherapeutic Efficacy	2017	67
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia Ingrid M. Ariës, Kimberly Bodaar, Salmaan Karim, The Journal of Experimental Medicine	2018	59
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia Filip Matthijssens, Nitesh Sharma, Monique Nysus, Journal of Clinical Investigation Mixed-phenotype Acute LeukemiaT-regulatory CellImmunologyLymphoblastic LeukemiaMyeloid Neoplasia	2021	44
Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia Steven Goossens, Sofie Peirs, Wouter Van Loocke, Blood	2017	25
A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an<i>ERG</i>-driven transcriptional network Ashwin Unnikrishnan, Yi Fang Guan, Yizhou Huang, Nucleic Acids Research	2016	20
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia Gayle P. Pouliot, James Degar, Laura Hinze, PLoS ONE Hematological MalignancyChromatinFanconi-brca Pathway MutationsSomatic VariantPoint Mutations	2019	20

Page 1